Investors Menu
Tilray, Inc. Reports 2020 Third Quarter Results
Total Revenue of $51.4 Million was Flat Versus Q3 2019 and Up 2.0% Compared to Q2 2020 - Excluding Bulk Sales in the Prior Year Period, Total Revenue Increased 25% Total Annualized Savings of Approximately $55 Million to be Achieved by Q4 2020 Net Loss of $(2.3) Million Versus Net Loss of $(36.4)
November 9, 2020
Tilray to Report Third Quarter 2020 Financial Results on November 9, 2020
NANAIMO, British Columbia --(BUSINESS WIRE)--Oct. 28, 2020-- Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the third quarter ended September 30, 2020 on Monday,
October 28, 2020
Highly-Anticipated Chowie Wowie Gummies added to High Park™ Edible Portfolio
Cann­abis-infused gummies expand High Park’s existing line-up of edible brands and products TORONTO --(BUSINESS WIRE)--Oct. 5, 2020-- High Park Holdings Ltd. (“High Park”), a wholly-owned subsidiary of Tilray, Inc. (NASDAQ: TLRY), today announced the newest addition to its cannabis-infused edible
October 5, 2020
Tilray, Inc. Reports 2020 Second Quarter Results
Revenue Increased 10% to $50.4 Million ( C$69.4 Million ) versus Q2 2019 Cost Savings of $13.0 Million Realized in Q2 2020 – on Pace for Total Annualized Savings of Approximately $55 Million   Net Loss of ($81.7) Million increased $45.4 Million versus Q2 2019 Partially Due to Facilities Closure and
August 10, 2020
Tilray to Report Second Quarter 2020 Financial Results on August 10, 2020
NANAIMO, British Columbia --(BUSINESS WIRE)--Jul. 27, 2020-- Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the second quarter ended June 30, 2020 on Monday, August
July 27, 2020
Tilray, Inc. to Participate in Two Upcoming Virtual Investor Events
NANAIMO, British Columbia --(BUSINESS WIRE)--Jun. 8, 2020-- Tilray, Inc. , (“ Tilray” or the “Company”) (Nasdaq: TLRY) a global leader in cannabis research, cultivation, production and distribution, today announced that management will participate in the following upcoming virtual investor events:
June 8, 2020
Tilray® Receives Complete GMP Certification at EU Campus
Licensing expands company’s international export capacity to serve authorized medical cannabis markets Provides authorization to complete medical cannabis extraction on-site and the production of bulk extracts to manufacture medical cannabis oil as a finished product Certification signals another
May 27, 2020